60 Degrees Pharmaceuticals Updates Investor Presentation (Sept 2026)

What Happened
60 Degrees Pharmaceuticals, Inc. (SXTP) filed a Current Report on Form 8-K on September 8, 2026 to disclose an updated investor presentation. The company furnished the presentation as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure) and said it intends to use the presentation in meetings with investors, analysts and other members of the investment community. The presentation is incorporated by reference into the filing.

Key Details

• Filing date: September 8, 2026 (Form 8-K, Item 7.01 and Item 9.01 exhibit furnished).
• Exhibit: Investor Presentation dated September 8, 2026 furnished as Exhibit 99.1.
• Purpose: To be used in investor, analyst and other investment community meetings (Regulation FD disclosure).
• The 8-K does not report earnings, executive changes, mergers/acquisitions, or other material financial results.

Why It Matters
Updated investor presentations often contain the company’s latest messaging on strategy, clinical pipeline, milestones, or upcoming events. For investors, this filing is a prompt to review the attached presentation (Exhibit 99.1) for any new disclosures or timeline updates that could affect the company’s outlook. Because this 8-K is a Regulation FD disclosure, it is intended to ensure material investor communications are publicly available; investors should read the exhibit for specifics.